// App-Quantinova.ai

Abstract 9388 : The ALPACA Study, an EHR Based Analysis of the Association of Elevated Alkaline Phosphatase With Cardiovascular Events

Researchers

Presenter

  • Philip Ambery

Principal Investigators

  • Fe Van-den-Broek

  • Irena Brookes-Smith

Medical Centers

  • Imperial College, Univ of London, London, United Kingdom

  • Real World Strategy & Capabilities, AstraZeneca, Cambridge, United Kingdom

  • Late-Stage Development CVRM, Astrazeneca, Molndal, Sweden

Locations

  • United Kingdom

  • Sweden

Companies

  • N/A

Study Components

Therapeutic Area

  • Angiology

  • Cardiovascular (CVS)

Disease

  • Acute Coronary Syndromes

  • Calcified vascular disease

  • Arrhythmia

  • Congestive heart failure

Biomarkers

  • Alkaline phosphatase

Drug/Treatment

  • Alkaline phosphatase

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved